Literature DB >> 12411626

Dyspnoea worsened by salmeterol.

John Fraser1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12411626      PMCID： PMC1279258          DOI： 10.1177/014107680209501113

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  6 in total

1.  [Risk factors for lung toxicity in pediatric cancer survivors].

Authors:  J A López Andreu; L Compte Torrero; J Ferrís Tortajada; R Domenech Clar; S Pérez Tarazona; C Pellicer Porres; H Cortina Orts; J M Roqués Serradilla
Journal:  An Esp Pediatr       Date:  1999-11

2.  Paradoxical bronchoconstriction in asthmatic patients after salmeterol by metered dose inhaler.

Authors:  J R Wilkinson; J A Roberts; P Bradding; S T Holgate; P H Howarth
Journal:  BMJ       Date:  1992-10-17

3.  The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy.

Authors:  J Congleton; M F Muers
Journal:  Respir Med       Date:  1995-04       Impact factor: 3.415

4.  Pulmonary drug toxicity in patients with primary breast cancer treated with high-dose combination chemotherapy and autologous bone marrow transplantation.

Authors:  N W Todd; W P Peters; A H Ost; V L Roggli; C A Piantadosi
Journal:  Am Rev Respir Dis       Date:  1993-05

5.  Dyspnea in the advanced cancer patient.

Authors:  D J Dudgeon; M Lertzman
Journal:  J Pain Symptom Manage       Date:  1998-10       Impact factor: 3.612

6.  Bleomycin associated pulmonary toxicity: is perioperative oxygen restriction necessary?

Authors:  S M Donat; D A Levy
Journal:  J Urol       Date:  1998-10       Impact factor: 7.450
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.